Besides promoting tumour angiogenesis through the stimulation of EC migration and proliferation, VEGF produced by tumour cells can modulate the function of CD8+ cytotoxic T lymphocytes and immune suppressive cells in the TME, inducing tumour-associated immunosuppression [8]. The gene discussed is CD8A; the disease is neoplasm.